Vaxess Technologies racks up $8.2 mln Series A
Cambridge, Massachusetts-based Vaxess Technologies, a biotechnology company, has closed its Series A funding round at $8.2 million. The Engine led the round.
28 June 2019•1 min read
Cambridge, Massachusetts-based Vaxess Technologies, a biotechnology company, has closed its Series A funding round at $8.2 million. The Engine led the round.
